You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – The US Food and Drug Administration has for the first time approved a drug to be given based on the genomic features in cancer patients' tumors, instead of where the tumor occurs in their bodies.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.
As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.